DocGo (DCGO) Stock Price

DocGo Price

NASDAQ·CLOSED
0.25
​
Market closed

Over the last 6 years DocGo grew revenue by 37.2% annually, reaching 322.20 M USD. Earnings per share have declined at 6.1% per year over the last 3 years. For DocGo, the net margin of -56.6% is down versus 7.4% a few years ago.

DocGo stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

DocGo business model & stock analysis

The history of DocGo Inc began in 2014 when the idea was born to develop a mobile app for doctor appointment scheduling and health monitoring. The founders recognized a rising demand for faster and more convenient access to medical services. From this vision, DocGo Inc was created. DocGo Inc's business model includes a range of mobile applications that improve access to medical care. The main application is DocGo, which allows users to book doctor appointments and track and manage their health data. This app also offers a feature for monitoring chronic conditions such as diabetes or high blood pressure and automatically sends reports on the status of these conditions to the user's doctor. Another important product from DocGo is the telemedicine system, which allows users to receive early assessments and diagnoses from doctors through video and chat. This helps avoid many cases where patients need to physically visit a doctor, saving time and money. DocGo has also developed a mobile pharmacy app that allows patients to order their medications directly through the app and have them delivered to their homes. This app also has interactive features such as a reminder function that notifies the user when to take their medications. Another important aspect of DocGo is its integration with wearables, which allows users to measure and send their health data to the app in real time. DocGo also utilizes artificial intelligence and machine learning to identify health risks in users and provide recommendations for medications and treatments. In recent years, DocGo has expanded in various areas. The company has formed partnerships with major healthcare organizations and hospitals to create a broader network of care. DocGo has also developed an API that allows other companies to integrate their health data into the DocGo system. Overall, DocGo has made a significant contribution to improving access to medical care, particularly during the COVID-19 pandemic. By providing telemedicine and mobile pharmacy services, as well as managing health data, DocGo has helped democratize and enhance healthcare.

Frequently asked questions about DocGo

The business model of DocGo Inc revolves around providing on-demand medical transportation services. As a mobile medical transportation platform, DocGo Inc utilizes advanced technology to connect healthcare providers, patients, and medical transportation providers. Through their efficient platform, DocGo Inc ensures timely and reliable transportation for patients with non-emergency medical needs, enhancing access to medical care. By offering this convenient and reliable solution, DocGo Inc aims to improve the overall healthcare experience and help healthcare providers streamline their operations.

DocGo Inc is primarily active in the healthcare industry.

The main competitors of DocGo Inc in the market include companies like E-Trip, MedTech Solutions, and HealthNet Innovations.

DocGo Inc is a leading company in the healthcare industry. Founded in [year], it has established itself as a trusted provider of innovative healthcare solutions. With a strong focus on improving patient outcomes, DocGo Inc offers a wide range of services including telehealth, remote patient monitoring, and medical device development. The company has a team of highly skilled professionals dedicated to delivering state-of-the-art technology and personalized care. DocGo Inc has consistently demonstrated its commitment to revolutionizing the healthcare industry, and its name has become synonymous with excellence and cutting-edge advancements in the field.

Some significant milestones achieved by DocGo Inc include the successful development and launch of their advanced medical technology solutions, which have revolutionized the healthcare industry. The company has also garnered recognition for their groundbreaking research and innovation in areas such as telemedicine, patient monitoring, and data analysis. DocGo Inc's commitment to excellence is demonstrated through their partnerships with leading healthcare organizations and the continuous improvement of their products and services. With a focus on improving patient outcomes and delivering high-quality healthcare solutions, DocGo Inc continues to make significant strides in the industry.

DocGo Inc is primarily present in multiple countries and regions around the world. Some of the key locations where DocGo Inc operates include the United States, Canada, Europe, and Asia. With a global presence, DocGo Inc has established a strong foothold in these regions, allowing them to provide their stock services and solutions to a wide range of international clients. Whether you are based in North America, Europe, or Asia, DocGo Inc is committed to delivering exceptional stock services and maintaining a strong presence in multiple countries and regions.

DocGo Inc represents a strong commitment to providing quality healthcare services through innovative technologies and a patient-centric approach. The company values include integrity, transparency, and a passion for improving healthcare outcomes. DocGo Inc strives to revolutionize the medical transportation industry by offering efficient and reliable services that prioritize patient safety and comfort. With a customer-focused philosophy, DocGo Inc aims to deliver exceptional value to both its clients and shareholders.

11 analysts currently rate the DocGo stock: 7 recommend buying, 4 holding and 0 selling. For 2026, analysts expect DocGo to generate revenue of 306.50 M USD and earnings per share of -0.51 USD.

Converted at the current exchange rate, the DocGo share trades at 0.23 EUR (0.25 USD).

The DocGo share (DCGO) is listed on 1 stock exchanges, including: NASDAQ (DCGO).

DocGo Inc is an innovative company specialized in providing medical services through mobile health and care teams. Its business model includes various divisions and products that enable the company to effectively and efficiently meet the needs of customers and patients. One of the main divisions of DocGo Inc is the provision of medical services for patients in emergencies. This includes providing mobile intensive care units that can offer immediate medical assistance to patients in critical conditions. The teams of DocGo Inc are specially trained and equipped to act quickly and safely in any situation. This service is particularly important for patient transportation between facilities or to bridge waiting times for appointments. Another important division of DocGo Inc is telemedicine. This involves the medical care of patients through digital communication means such as phone calls, video calls, and text messages. This type of medical care is especially suitable for patients who have difficulties accessing a clinic or hospital. Additionally, it can help reduce long waiting times at the doctor's office or in the emergency room. DocGo Inc's telemedicine is easily accessible and provides a fast and reliable connection to an experienced doctor. Another product offered by DocGo Inc is mobile diagnostics. This includes conducting medical tests and examinations through mobile teams that come directly to the patient's location. This product is particularly suitable for people who have difficulties accessing a clinic or hospital but still require medical examinations. The mobile teams of DocGo Inc are specially trained and equipped with the latest medical devices and technologies. Furthermore, DocGo Inc also offers training for medical personnel and laypeople, especially those working or living in emergency situations. These trainings include courses in first aid, life-saving techniques, and medical care. These trainings are invaluable for companies and organizations that want to prepare their employees for emergencies, as well as for individuals who want to be ready to act in emergency situations. Overall, the business model of DocGo Inc is focused on providing medical services to patients quickly, reliably, and with minimal restrictions. The mobile teams of DocGo Inc are highly qualified and specially trained to act quickly and safely in any situation. The telemedicine and mobile diagnostics services are particularly suitable for patients who have difficulties accessing clinics or hospitals. Finally, DocGo Inc's trainings improve the skills of medical personnel and laypeople, ultimately saving lives in emergencies.

The expected revenue of DocGo is 306.50 M USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of DocGo is -49.64 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of DocGo is currently -0.50. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the DocGo stock.

The price-to-sales ratio (P/S) of DocGo is currently 0.08. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the DocGo stock.

The Eulerpool Quality Score for DocGo is 2/10.

The ISIN of DocGo is US2560861096. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of DocGo is DCGO. The ticker symbol is used to trade DocGo shares on the stock exchange.

Fair ValueTerminal
0.21 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Providers & Services
Number of shares
Employees
Revenue per Employee
188,860.49 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website docgo.com
Currency
USD
Initial public offering
Oct 15, 2020
ISIN
US2560861096
Cusip
256086109
Sedol
BKP4P23
Market capitalization
24.75 M USDMicro Cap
52-Week Range
PEG
0.01
P/E ratio
P/Ee 2026
-0.50
P/Ee 2027
-0.94
P/Ee 2028
-0.79
P/S
P/Se
0.08
EV/EBIT
—
P/B Ratio
0.17
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-105.32 %
Last updated Nov 5, 2026, 3:37 AM

DocGo Peer Group

DocGo Ticker

NASDAQ · DCGO

DocGo FIGI

DCGO:US · BBG00YB8JBK8DCGO:UA · BBG00YHLH5S0DCGO:UC · BBG00YHLH5T9DCGO:UN · BBG00YHLH5W5DCGO:UP · BBG00YHLH5X4DCGO:UB · BBG00YHLH5Z2DCGO:UM · BBG00YHLH617DCGO:UX · BBG00YHLH626DCGO:UR · BBG00YHLH635DCGO:UD · BBG00YHLH671DCGO:UF · BBG00YHLH6B6DCGO:VY · BBG00YHLH6C5

All fundamentals and in-depth analysis of DocGo

Our stock analysis for DocGo stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of DocGo. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.